The company have always said the rights issue was to fund stage 1 of the DFT, stages 2 and 3 were to be funded by other options. The board was in the process of reviewing these options in the 10 Jan announcement.
So far the NEW board has worked to a carefully laid out plan, so I can only assume they also know what they are doing regarding funding stages 2 and 3.
I guess we will know more early March when the EGM is announced.
The company have always said the rights issue was to fund stage...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ECT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(28.6%) |
Mkt cap ! $7.929M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $43.54K | 14.60M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 17485353 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 6605665 | 5 |
View Market Depth
| Last trade - 15.59pm 25/07/2024 (20 minute delay) ? |
| ECT (ASX) Chart |